← Back to patent-cliff list
CAS 1421374-93-7
(3aR,4S,7R,7aS)-2-(((1R,2R)-2-(hydroxymethyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione
Codes：LURA-015
Application context (from source-drug indications)
重度抑郁症盐酸鲁拉西酮精神分裂症盐酸鲁拉西酮躁狂症盐酸鲁拉西酮抑郁症盐酸鲁拉西酮
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 盐酸鲁拉西酮Lurasidone Hydrochloride | Tier B — Position early | 2028 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3-(piperazin-1-yl)benzo[d]isothiazole→((1R,2R)-2-(aminomethyl)cyclohexyl)methanol→(3aR,4S,7R,7aS)-hexahydro-4,7-methanoisobenzofuran-1,3-dione→(3aR,4S,7R,7aS)-2-(((1R,2R)-2-(hydroxymethyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione→((1R,2R)-2-(((3aR,4S,7R,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl)methyl)cyclohexyl)methyl methanesulfonate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.